Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1257 - 1264 of 11616 results
EXCLUSIVE RIGHTS: Intellectual Property — Avoiding Pitfalls: IP “Dos and Don’ts” for High-Tech Start-Ups
May 11, 2023| Podcast| Viewpoint
New York Joins Other States with Health Care Transaction Review Laws
May 11, 2023| Blog| Viewpoint
Heightened Risk for Banks as Account Fees Land on “Junk Fee” Agenda
May 11, 2023| Blog| Viewpoint
Nothing for free – the real costs of ChatGPT
May 11, 2023| Blog| Viewpoint
Feds Bring 18 Charges in Covid Crackdown, Lab Implicated
May 10, 2023| News
Making Bacon Still Requires a Significant Contribution for Joint Inventorship
May 10, 2023| Blog| Viewpoint
Acquiring U.S. Businesses: Considerations for European Companies and Private Equity Funds
May 9, 2023| Advisory| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.